Rivervest Venture Fund Iv, L.p. - Net Worth and Insider Trading
Rivervest Venture Fund Iv, L.p. Net Worth
The estimated net worth of Rivervest Venture Fund Iv, L.p. is at least $3 Million dollars as of 2024-11-10. Rivervest Venture Fund Iv, L.p. is the 10% Owner of Xilio Therapeutics Inc and owns about 2,632,888 shares of Xilio Therapeutics Inc (XLO) stock worth over $3 Million. Details can be seen in Rivervest Venture Fund Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rivervest Venture Fund Iv, L.p. has not made any transactions after 2021-10-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rivervest Venture Fund Iv, L.p.
Rivervest Venture Fund Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rivervest Venture Fund Iv, L.p. owns 3 companies in total, including Spruce Biosciences Inc (SPRB) , Reneo Pharmaceuticals Inc (RPHM) , and Xilio Therapeutics Inc (XLO) .
Click here to see the complete history of Rivervest Venture Fund Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Rivervest Venture Fund Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRB | Spruce Biosciences Inc | 2020-10-08 | 10 percent owner |
| RPHM | Reneo Pharmaceuticals Inc | 2021-04-08 | 10 percent owner |
| XLO | Xilio Therapeutics Inc | 2021-10-26 | 10 percent owner |
Rivervest Venture Fund Iv, L.p. Latest Holdings Summary
Rivervest Venture Fund Iv, L.p. currently owns a total of 1 stock. Rivervest Venture Fund Iv, L.p. owns 2,632,888 shares of Xilio Therapeutics Inc (XLO) as of October 26, 2021, with a value of $3 Million.
Latest Holdings of Rivervest Venture Fund Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XLO | Xilio Therapeutics Inc | 2021-10-26 | 2,632,888 | 0.99 | 2,606,822 |
Holding Weightings of Rivervest Venture Fund Iv, L.p.
Rivervest Venture Fund Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Rivervest Venture Fund Iv, L.p. has made a total of 1 transactions in Xilio Therapeutics Inc (XLO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xilio Therapeutics Inc is the acquisition of 250,000 shares on October 26, 2021, which cost Rivervest Venture Fund Iv, L.p. around $4 Million.
Insider Trading History of Rivervest Venture Fund Iv, L.p.
- 1
Rivervest Venture Fund Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Rivervest Venture Fund Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rivervest Venture Fund Iv, L.p. is -15.32%. GuruFocus also compares Rivervest Venture Fund Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Rivervest Venture Fund Iv, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rivervest Venture Fund Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Rivervest Venture Fund Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.03 | | | | | |
| Relative Return to S&P 500(%) | 20.6 | | | | | |
Rivervest Venture Fund Iv, L.p. Ownership Network
Ownership Network List of Rivervest Venture Fund Iv, L.p.
Ownership Network Relation of Rivervest Venture Fund Iv, L.p.
Rivervest Venture Fund Iv, L.p. Owned Company Details
What does Spruce Biosciences Inc do?
Who are the key executives at Spruce Biosciences Inc?
Rivervest Venture Fund Iv, L.p. is the 10 percent owner of Spruce Biosciences Inc. Other key executives at Spruce Biosciences Inc include 10 percent owner Novo Holdings A/s , Chief Medical Officer Charlton Ralph William Iii , and director & Chief Executive Officer Javier B. Szwarcberg .
Spruce Biosciences Inc (SPRB) Insider Trades Summary
Over the past 18 months, Rivervest Venture Fund Iv, L.p. made no insider transaction in Spruce Biosciences Inc (SPRB). Other recent insider transactions involving Spruce Biosciences Inc (SPRB) include a net sale of 4,172,336 shares made by Novo Holdings A/s ,
In summary, during the past 3 months, insiders sold 0 shares of Spruce Biosciences Inc (SPRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,172,336 shares of Spruce Biosciences Inc (SPRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,172,336 shares.
Spruce Biosciences Inc (SPRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spruce Biosciences Inc Insider Transactions
Rivervest Venture Fund Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Rivervest Venture Fund Iv, L.p.. You might contact Rivervest Venture Fund Iv, L.p. via mailing address: 101 South Hanley Road, Suite 1850, St. Louis Mo 63105.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
